Today, Baxter International Inc. (BAX) Stake Held by North Star Investment Management Corp.

Today, Baxter International Inc. (BAX) Stake Held by North Star Investment Management Corp.

North Star Investment Management Corp. maintained its position in Baxter International Inc. (NYSE:BAX) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,078 shares of the company’s stock at the end of the third quarter. North Star Investment Management Corp.’s holdings in Baxter International were worth $242,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in BAX. Oregon Public Employees Retirement Fund raised its position in Baxter International by 2.7% in the third quarter. Oregon Public Employees Retirement Fund now owns 136,553 shares of the company’s stock worth $6,500,000 after buying an additional 3,640 shares in the last quarter. Stillwater Investment Management LLC raised its position in Baxter International by 3.0% in the third quarter. Stillwater Investment Management LLC now owns 19,967 shares of the company’s stock worth $950,000 after buying an additional 588 shares in the last quarter. West Oak Capital LLC raised its position in Baxter International by 30.1% in the third quarter. West Oak Capital LLC now owns 6,049 shares of the company’s stock worth $288,000 after buying an additional 1,400 shares in the last quarter. LVM Capital Management Ltd. MI raised its position in Baxter International by 1,768.5% in the third quarter. LVM Capital Management Ltd. MI now owns 116,480 shares of the company’s stock worth $8,422,000 after buying an additional 110,246 shares in the last quarter. Finally, IFP Advisors Inc raised its position in Baxter International by 0.5% in the second quarter. IFP Advisors Inc now owns 18,075 shares of the company’s stock worth $817,000 after buying an additional 95 shares in the last quarter. 86.14% of the stock is currently owned by institutional investors and hedge funds.

Baxter International Inc. (NYSE:BAX) traded up 0.34% during midday trading on Friday, reaching $46.72. 1,117,020 shares of the company traded hands. The stock’s 50 day moving average is $47.27 and its 200 day moving average is $46.44. The company has a market capitalization of $25.41 billion, a price-to-earnings ratio of 5.23 and a beta of 0.88. Baxter International Inc. has a one year low of $34.06 and a one year high of $50.16.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Tuesday, October 25th. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.11. Baxter International had a return on equity of 11.43% and a net margin of 48.68%. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.67 billion. During the same period last year, the company earned $0.41 earnings per share. The company’s revenue was up 2.9% on a year-over-year basis. On average, equities analysts anticipate that Baxter International Inc. will post $1.91 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 3rd. Stockholders of record on Friday, December 2nd will be issued a dividend of $0.13 per share. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $0.52 annualized dividend and a dividend yield of 1.11%. Baxter International’s payout ratio is presently 5.83%.

A number of research firms recently commented on BAX. RBC Capital Markets reaffirmed a “sector perform” rating and set a $55.00 price target (up from $50.00) on shares of Baxter International in a research report on Wednesday, October 26th. Evercore ISI reaffirmed a “buy” rating and set a $56.00 price target (up from $52.00) on shares of Baxter International in a research report on Wednesday, October 26th. Royal Bank Of Canada raised their price target on shares of Baxter International from $50.00 to $55.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 26th. Zacks Investment Research lowered shares of Baxter International from a “buy” rating to a “hold” rating in a report on Monday, October 17th. Finally, Wells Fargo & Co. initiated coverage on shares of Baxter International in a report on Thursday, October 13th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $51.30.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services.

Related posts

Leave a Comment